Literature DB >> 18359520

Cloning the complete guinea pig cytomegalovirus genome as an infectious bacterial artificial chromosome with excisable origin of replication.

Xiaohong Cui1, Alistair McGregor, Mark R Schleiss, Michael A McVoy.   

Abstract

Congenital human cytomegalovirus infections are the major infectious cause of birth defects in the United States. How this virus crosses the placenta and causes fetal disease is poorly understood. Guinea pig cytomegalovirus (GPCMV) is a related virus that provides an important model for studying cytomegaloviral congenital transmission and pathogenesis. In order to facilitate genetic analysis of GPCMV, the 232kb GPCMV genome was cloned as an infectious bacterial artificial chromosome (BAC). The BAC vector sequences were flanked by LoxP sites to allow efficient excision using Cre recombinase. All initial clones contained spontaneous deletions of viral sequences and reconstituted mutant viruses with impaired growth kinetics in vitro. The deletions in one BAC were repaired using Escherichia coli genetics. The resulting repaired BAC reconstituted a virus with in vitro replication kinetics identical to the wild type parental virus; moreover, its genome was indistinguishable from that of the wild type parental virus by restriction pattern analysis using multiple restriction enzymes. These results suggest that the repaired BAC is an authentic representation of the complete GPCMV genome. It should provide a valuable tool for evaluating the impact of genetic modifications on the safety and efficacy of live attenuated vaccines and for identifying genes important for congenital transmission and fetal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18359520      PMCID: PMC2831993          DOI: 10.1016/j.jviromet.2008.01.031

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  27 in total

1.  Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene.

Authors:  Dong Yu; Gregory A Smith; Lynn W Enquist; Thomas Shenk
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Functional map of human cytomegalovirus AD169 defined by global mutational analysis.

Authors:  Dong Yu; Maria C Silva; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

3.  Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis.

Authors:  W L William Chang; Peter A Barry
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism.

Authors:  Cary A Rue; Michael A Jarvis; Amber J Knoche; Heather L Meyers; Victor R DeFilippis; Scott G Hansen; Markus Wagner; Klaus Früh; David G Anders; Scott W Wong; Peter A Barry; Jay A Nelson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs.

Authors:  A Chatterjee; C J Harrison; W J Britt; C Bewtra
Journal:  J Infect Dis       Date:  2001-04-27       Impact factor: 5.226

6.  Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.

Authors:  Mark R Schleiss; Nigel Bourne; Greg Stroup; Fernando J Bravo; Nancy J Jensen; David I Bernstein
Journal:  J Infect Dis       Date:  2004-04-01       Impact factor: 5.226

7.  Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo.

Authors:  Luka Cicin-Sain; Wolfram Brune; Ivan Bubic; Stipan Jonjic; Ulrich H Koszinowski
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli.

Authors:  A McGregor; M R Schleiss
Journal:  Mol Genet Metab       Date:  2001-01       Impact factor: 4.797

Review 9.  Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV).

Authors:  Mark R Schleiss
Journal:  J Clin Virol       Date:  2002-08       Impact factor: 3.168

10.  Tn7-mediated introduction of DNA sequences into bacmid-cloned cytomegalovirus genomes for rapid recombinant virus construction.

Authors:  Gabriele Hahn; Margit Jarosch; Jian Ben Wang; Carlos Berbes; Michael A McVoy
Journal:  J Virol Methods       Date:  2003-02       Impact factor: 2.014

View more
  34 in total

1.  Human cytomegalovirus: bacterial artificial chromosome (BAC) cloning and genetic manipulation.

Authors:  Anne M Paredes; Dong Yu
Journal:  Curr Protoc Microbiol       Date:  2012-02

2.  A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  J Gen Virol       Date:  2021-03-17       Impact factor: 3.891

3.  Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.

Authors:  Mark R Schleiss; Craig J Bierle; Elizabeth C Swanson; Michael A McVoy; Jian Ben Wang; Zainab Al-Mahdi; Adam P Geballe
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 4.  Recent advances in cloning herpesviral genomes as infectious bacterial artificial chromosomes.

Authors:  Fuchun Zhou; Shou-Jiang Gao
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

5.  Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells.

Authors:  Frances M Saccoccio; Anne L Sauer; Xiaohong Cui; Amy E Armstrong; El-Sayed E Habib; David C Johnson; Brent J Ryckman; Aloysius J Klingelhutz; Stuart P Adler; Michael A McVoy
Journal:  Vaccine       Date:  2011-02-22       Impact factor: 3.641

Review 6.  Cytomegalovirus antivirals and development of improved animal models.

Authors:  Alistair McGregor; K Yeon Choi
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-09-01       Impact factor: 4.481

7.  The essential role of guinea pig cytomegalovirus (GPCMV) IE1 and IE2 homologs in viral replication and IE1-mediated ND10 targeting.

Authors:  Julia Hornig; K Yeon Choi; Alistair McGregor
Journal:  Virology       Date:  2017-02-10       Impact factor: 3.616

8.  The impact of genome length on replication and genome stability of the herpesvirus guinea pig cytomegalovirus.

Authors:  Xiaohong Cui; Alistair McGregor; Mark R Schleiss; Michael A McVoy
Journal:  Virology       Date:  2009-01-26       Impact factor: 3.616

9.  Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  J Gen Virol       Date:  2020-02-18       Impact factor: 3.891

10.  Autoexcision of bacterial artificial chromosome facilitated by terminal repeat-mediated homologous recombination: a novel approach for generating traceless genetic mutants of herpesviruses.

Authors:  Fuchun Zhou; Qiuhua Li; Scott W Wong; Shou-Jiang Gao
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.